Cardiovascular Center, Yokohama City University Medical Center, Yokohama, Japan.
Cardiovascular Center, Yokohama City University Medical Center, Yokohama, Japan.
J Thorac Cardiovasc Surg. 2018 Aug;156(2):483-489. doi: 10.1016/j.jtcvs.2018.02.007. Epub 2018 Feb 13.
The control of malperfusion is the key to improving the outcomes of surgery for type A acute aortic dissection. We revised our treatment strategy to reperfuse each ischemic organ before central repair.
Our current early reperfusion strategy consists of percutaneous coronary artery intervention for coronary malperfusion, direct surgical fenestration for carotid artery occlusion, active perfusion of the superior mesenteric artery for visceral malperfusion, and external shunting from the brachial artery to the femoral artery for lower limb ischemia. Central repair is performed without delay after reperfusion therapy, but if irreversible organ damage is recognized, further aggressive treatment is discontinued.
Among 438 patients who underwent initial treatment for type A acute aortic dissection, malperfusion in one or more organs was diagnosed in 108 patients (24%). We applied an early reperfusion strategy in 33 patients, (coronary, 14 patients; carotid, 4; visceral, 7; lower extremity, 8). Central repair was then performed in 28 patients. One patient (3.6%) died of pneumonia; 27 patients overcame the ischemic organ damage and survived. Among the 108 patients with malperfusion, 10 patients (9.3%) were treated medically without early reperfusion and central repair. During the same period, mortality from central repair procedures in patients with malperfusion who had not received early reperfusion therapy was 12 of 65 (18%), and the mortality of patients without malperfusion was 9 of 262 (3.4%). Malperfusion was a serious risk factor for hospital death, but the mortality rate of the patients with an early reperfusion strategy was significantly (P < .01) lower than the patients without early reperfusion.
Our strategy might improve the outcomes of surgery for type A acute aortic dissection with malperfusion. This strategy enables us to avoid unproductive central repair procedures in irreversibly damaged patients.
控制血运障碍是改善 A 型急性主动脉夹层手术结果的关键。我们修改了治疗策略,以便在中央修复前对每个缺血器官进行再灌注。
我们目前的早期再灌注策略包括经皮冠状动脉介入治疗冠状动脉灌注不良、颈动脉闭塞直接手术开窗、肠系膜上动脉主动灌注内脏灌注不良以及肱动脉至股动脉外分流治疗下肢缺血。再灌注治疗后立即进行中央修复,但如果发现不可逆的器官损伤,则停止进一步积极治疗。
在 438 例接受 A 型急性主动脉夹层初始治疗的患者中,108 例(24%)诊断为一个或多个器官灌注不良。我们对 33 例患者应用了早期再灌注策略,包括冠状动脉灌注不良 14 例、颈动脉灌注不良 4 例、内脏灌注不良 7 例、下肢缺血 8 例。然后对 28 例患者进行了中央修复。1 例(3.6%)死于肺炎;27 例患者克服了缺血性器官损伤并存活。在 108 例灌注不良患者中,10 例(9.3%)未经早期再灌注和中央修复而接受药物治疗。同期,未接受早期再灌注治疗的灌注不良患者中央修复术死亡率为 12/65(18%),无灌注不良患者死亡率为 9/262(3.4%)。灌注不良是院内死亡的严重危险因素,但早期再灌注策略患者的死亡率明显低于未接受早期再灌注的患者(P<.01)。
我们的策略可能改善灌注不良的 A 型急性主动脉夹层手术的结果。该策略使我们能够避免对不可逆损伤患者进行无益的中央修复手术。